Formulating a Sulfonated Antiviral Dendrimer in a Vaginal Microbicidal Gel Having Dual Mechanisms of Action

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drug Development and Industrial Pharmacy

• Publication date

  2009-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/03639040802488097PMID 19040181PMCID PMC2756599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial

  2010cited by this paper
• Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides

  2008cited by this paper
• Mucosal Irritation Potential of Personal Lubricants Relates to Product Osmolality as Detected by the Slug Mucosal Irritation Assay

  2008cited by this paper
• Unacceptable side effects of a hyperosmolar vaginal microbicide in a phase 1 trial.

  2008influential reference
• A Review of Current Intravaginal Drug Delivery Approaches Employed for the Prophylaxis of HIV/AIDS and Prevention of Sexually Transmitted Infections

  2008cited by this paper
• A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.

  2008cited by this paper
• Preclinical Testing of Candidate Topical Microbicides for Anti-Human Immunodeficiency Virus Type 1 Activity and Tissue Toxicity in a Human Cervical Explant Culture

  2007cited by this paper
• Phase I Safety Trial of Two Vaginal Microbicide Gels (Acidform or BufferGel) Used With a Diaphragm Compared to KY Jelly Used With a Diaphragm

  2007cited by this paper
• Effect of Topical Microbicides on Infectious Human Immunodeficiency Virus Type 1 Binding to Epithelial Cells

  2007cited by this paper
• Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women.

  2007cited by this paper
• VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection

  2007cited by this paper
• Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission

  2006cited by this paper
• Analytical ultracentrifugation for the study of protein association and assembly.

  2006cited by this paper
• Nearly 40 million people worldwide are infected with HIV

  2006cited by this paper
• Shell click-crosslinked (SCC) nanoparticles: a new methodology for synthesis and orthogonal functionalization.

  2005cited by this paper
• SPL7013 Gel as a Topical Microbicide for Prevention of Vaginal Transmission of SHIV89.6P in Macaques

  2005cited by this paper
• In Vitro and in Vivo Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials

  2005cited by this paper
• Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses.

  2005cited by this paper
• Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model

  2005cited by this paper
• In brief

  2005cited by this paper
• Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention.

  2005cited by this paper
• A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection.

  2005cited by this paper
• Safety and Efficacy Evaluations for Vaginal and Rectal Use of BufferGel in the Macaque Model

  2004cited by this paper
• Monitoring the in Vivo Delivery of Proteins from Carbomer Hydrogels by X-Ray Fluorescence

  2003cited by this paper
• Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes

  2003cited by this paper
• Assessing the contribution of the herpes simplex virus DNA polymerase to spontaneous mutations

  2002cited by this paper
• Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides

  2002cited by this paper
• Considerations and development of topical microbicides to inhibit the sexual transmission of HIV

  2002cited by this paper
• Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites

  2001cited by this paper
• Diffusion of macromolecules and virus-like particles in human cervical mucus.

  2001cited by this paper
• Comparison of Microbicides for Efficacy in Protecting Mice Against Vaginal Challenge With Herpes Simplex Virus Type 2, Cytotoxicity, Antibacterial Properties, and Sperm Immobilization

  2001cited by this paper
• Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.

  2001cited by this paper
• Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models

  2001cited by this paper
• The rate at which human sperm are immobilized and killed by mild acidity.

  2000cited by this paper
• Entropic trapping of macromolecules by mesoscopic periodic voids in a polymer hydrogel

  1999cited by this paper
• Adherent surface mucus gel restricts diffusion of macromolecules in rat duodenum in vivo.

  1999cited by this paper
• Adherent surface mucus gel restricts diffusion of macromolecules in rat duodenum in vivo.

  1999cited by this paper

• Phenothiazine-linked glutamic acid dendrons: an easy access and a new class of SARS-CoV-2 main protease inhibitors

  2025cites this paper
• Peptide dendrimers: Novel therapeutic opportunities for peptide-based biomaterials in biomedicine.

  2025cites this paper
• Synthesis, evaluation and modification of heterofunctional polyester dendrimers with internally queued bromide groups.

  2024cites this paper
• Baseline and time‐updated factors in preclinical development of anionic dendrimers as successful anti‐HIV‐1 vaginal microbicides

  2022cites this paper
• Progresses In Nano-Enabled Platforms For The Treatment Of Vaginal Disorders.

  2022cites this paper
• Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies

  2022cites this paper
• Antiviral Polymers: A Review

  2022cites this paper
• Peptides and Dendrimers: How to Combat Viral and Bacterial Infections

  2021cites this paper
• Recent Advances in Polymer-Based Vaginal Drug Delivery Systems

  2021influential citation
• In vitro anti-inflammatory potential of phloretin microemulsion as a new formulation for prospective treatment of vaginitis

  2020cites this paper
• Designer Peptide and Protein Dendrimers: A Cross-Sectional Analysis.

  2019cites this paper
• Dendrimers in the context of nanomedicine.

  2019cites this paper
• Anti-HIV-1 activity and safety profile of a polyherbal gel formulation as a candidate microbicide

  2019cites this paper
• Nanomedicine in the development of anti-HIV microbicides.

  2016cites this paper
• CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array.

  2014influential citation
• Poly(ethylene glycol) (PEG)-lactic acid nanocarrier-based degradable hydrogels for restoring the vaginal microenvironment.

  2014cites this paper
• Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?

  2013cites this paper
• Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells

  2013cites this paper
• Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis.

  2012cites this paper
• Enhanced bioactivity of internally functionalized cationic dendrimers with PEG cores.

  2012cites this paper
• Poly(amidoamine) dendrimers increase antifungal activity of clotrimazole.

  2011cites this paper
• Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.

  2011cites this paper
• Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation.

  2011cites this paper
• Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study

  2010cites this paper
• Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates.

  2010influential citation
• Transport and Biodistribution of Dendrimers Across Human Fetal Membranes: Implications for Intravaginal Administration of Dendrimers

  2010influential citation
• Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine.

  2010cites this paper
• A novel controlled release intravaginal bioadhesive polymeric device

  2010cites this paper
• Interactions and encapsulation of vitamins C, B3, and B6 with dendrimers in water.

  2010cites this paper
• Synthesis of carbosilane dendrons and dendrimers derived from 1,3,5-trihydroxybenzene

  2010cites this paper
• Pre-clinical and behavioural toxicity profile of PAMAM dendrimers in mice

  2010cites this paper
• Targeting Trojan Horse leukocytes for HIV prevention

  2010cites this paper
• Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers.

  2010cites this paper